Hims & Hers CEO says FTC lawsuit misunderstands how the company works

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.

What happened?

Hims & Hers CEO Andrew Dudum defended the telehealth company amid a Federal Trade Commission lawsuit over its data sharing practices. In a wide-ranging exclusive interview aired Tuesday, Dudum contended the allegations stemmed from a misunderstanding of how the company is altering healthcare. "I can't say much other than the fact that, you know when you're changing the fundamental understanding of how a traditional system like healthcare works, and you're rebuilding it in the digital ecosystem," he told Andrew Ross Sorkin on CNBC's "Squawk Box." "I think it takes time for people to understand how to do that the right way, and we've worked for many years with the FTC to walk them through that. And I think ultimately they wanted more of a headline than than a real agreement here." In July, the FTC, Los Angeles County and Utah filed a lawsuit against Hims & Hers. It accused the company o...

Why it matters

This update may affect readers, businesses, investors, students, job seekers, and local communities depending on the topic. Local Listing Hub tracks these updates to help visitors follow important news in one place.

What to watch next

Readers should follow verified updates from the original source and official announcements as the story develops.

FAQs

Why is this important?

This update helps readers understand current trends, risks, and opportunities.

Where can I read the original report?

Use the source link on this page to read the publisher report.